130 related articles for article (PubMed ID: 19609744)
1. HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor.
Ragab SM; Samaka RM; Shams TM
Pathol Oncol Res; 2010 Mar; 16(1):61-7. PubMed ID: 19609744
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
Salama A; Kamel A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
[TBL] [Abstract][Full Text] [Related]
3. Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings.
Babashahi M; Mehrazma M; Nasiri SJ; Azizi Jalilian F; Rezaei-Tavirani M
Iran J Cancer Prev; 2013; 6(3):160-4. PubMed ID: 25250127
[TBL] [Abstract][Full Text] [Related]
4. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
5. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.
Yokoi A; McCrudden KW; Huang J; Kim ES; Soffer SZ; Frischer JS; Serur A; New T; Yuan J; Mansukhani M; O'toole K; Yamashiro DJ; Kandel JJ
J Pediatr Surg; 2003 Nov; 38(11):1569-73. PubMed ID: 14614702
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival.
Haque AK; Syed S; Lele SM; Freeman DH; Adegboyega PA
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):103-9. PubMed ID: 12051626
[TBL] [Abstract][Full Text] [Related]
8. Association between the HER2 expression and histological differentiation in Wilms tumor.
Salem M; Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Kohashi K; Tsuneyoshi M; Taguchi T
Pediatr Surg Int; 2006 Nov; 22(11):891-6. PubMed ID: 16932912
[TBL] [Abstract][Full Text] [Related]
9. Expression of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Wilms Tumor.
Ersavaş S; Diniz G; Yildirim HT; Koca Y; Kahraman DS; Ayaz D; Demirağ B
Turk Patoloji Derg; 2016; 32(3):158-63. PubMed ID: 27562389
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
11. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
[TBL] [Abstract][Full Text] [Related]
12. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
13. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.
Guo F; Zhang LJ; Liu W; Wang G; Liu HY; Wang YL; Ma R; Wu RD
J Pediatr Urol; 2014 Apr; 10(2):317-23. PubMed ID: 24119914
[TBL] [Abstract][Full Text] [Related]
15. Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor.
Yokoi A; McCrudden KW; Huang J; Kim ES; Soffer SZ; Frischer JS; Serur A; New T; Yuan J; Mansukhani M; O'Toole K; Yamashiro DJ; Kandel JJ
Oncol Rep; 2003; 10(5):1271-4. PubMed ID: 12883692
[TBL] [Abstract][Full Text] [Related]
16. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
17. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
Yang Y; Niu ZB; Hou Y; Wang CL
J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
[TBL] [Abstract][Full Text] [Related]
18. [Tumor size and prognosis in patients with Wilms tumor].
Provenzi VO; Rosa RF; Rosa RC; Roehe AV; dos Santos PP; Faulhaber FR; de Oliveira CA; Zen PR
Rev Paul Pediatr; 2015; 33(1):82-7. PubMed ID: 25623730
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
